The Company is in the process of accelerating an increase to near-term production capacity with
an aim to accelerate the path to market. This step-up is expected to occur during the current fiscal
year (ending June 2024), so that WOA can support larger order volumes of Buntine Protein®.
WOA will provide an update on its commercial production plans when they are finalised.
At some point they'll need to disclose the production partner and hopefully have the ASX suspension lifted ...how much longer we will have to wait is anyone's guess.
Ann: WOA Partners with Alchemy Agencies for Sales Distribution, page-9
Add WOA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $4.803M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $1.213K | 121.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2369973 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1411701 | 4 |
View Market Depth
| Last trade - 12.21pm 15/11/2024 (20 minute delay) ? |
| WOA (ASX) Chart |